| Literature DB >> 32325657 |
Abstract
Tissue adhesives have attracted more attention to the applications of non-invasive wound closure. The purpose of this review article is to summarize the recent progress of developing tissue adhesives, which may inspire researchers to develop more outstanding tissue adhesives. It begins with a brief introduction to the emerging potential use of tissue adhesives in the clinic. Next, several critical mechanisms for adhesion are discussed, including van der Waals forces, capillary forces, hydrogen bonding, static electric forces, and chemical bonds. This article further details the measurement methods of adhesion and highlights the different types of adhesive, including natural or biological, synthetic and semisynthetic, and biomimetic adhesives. Finally, this review article concludes with remarks on the challenges and future directions for design, fabrication, and application of tissue adhesives in the clinic. This review article has promising potential to provide novel creative design principles for the generation of future tissue adhesives.Entities:
Keywords: applications; biomimetic adhesives; natural adhesives; synthetic adhesives; tissue adhesives
Year: 2020 PMID: 32325657 PMCID: PMC7240468 DOI: 10.3390/polym12040939
Source DB: PubMed Journal: Polymers (Basel) ISSN: 2073-4360 Impact factor: 4.329
Figure 1The schematic illustration of preparing multifunctional GelMA-TA hydrogel with high stiffness, super-elasticity, deformability (A), and in vivo self-healing and adhesive property (B). Biomedical applications of GelMA-TA gel for skin wound closure (C), sutureless gastric surgery (D). 49 Copyright 2018, Elsevier.
Figure 2The types of peel tests, including 180 degrees peel (A), peel wheel (B), T-peel (C), Floating roller (115 degrees) (D), floating roller or (without rollers) moving table (E). The schematic of lap shear tests (F). Citing from http://www.mecmesin.com/peel-test-adhesion-testing.
Common commercially available tissue adhesives for medical devices.
| Categories | Commerical Product | Manufacturer | Constituents |
|---|---|---|---|
| Natural or biological adhesives | Crosseal | Omrix | Human fibrinogen, human thrombin, human fibronectin, human factor XIII, calcium chloride |
| TachoSil | Pharmaceuticals International GmbH | Equine collagen patch, human fibrinogen, human thrombin | |
| Vitagel | Stryker | Bovine collagen, bovine thrombin, patients own plasma | |
| GRF | Microval | Gelatin, resorcinol, formaldehyde, glutaraldehyde | |
| ProGel | NeoMend | Human Serum Albumin, PEG di NHS | |
| Tisseel | Baxter | Human fibrinogen, human fibronectin, human thrombin, human Factor XIII, bovine aprotinin, calcium chloride | |
| Artiss | Baxter | Human pooled plasma | |
| Evicel | Ethicon | Human fibrinogen, human thrombin, human factor XIII, calcium chloride | |
| CryoSeal | Thermogen | Human fibrinogen, human thrombin, human fibronectin, human Factor XIII, human Factor VIII, human vWF, human thrombin from individual units of plasma | |
| Hemaseel | Haemacure Corp. | Human fibrinogen, human fibronectin, human factor XIII, bovine thrombin, calcium chloride | |
| BioGlue | CryoLife | Albumin, glutaraldehyde | |
| synthetic polymer-based tissue adhesive | Histoacryl | B. Braun | n-Butyl-2-cyanoacrylate |
| Dermabond | Ethicon | 2-Octyl-2-cyanoacrylate | |
| Octylseal | Medline Industries | 2-Octyl-2-cyanoacrylate | |
| Surgiseal | Adhezion Biomedical | 2-Octyl-2-cyanoacrylate | |
| Omnex | Ethicon | n-Octyl-2-cyanoacrylate/butyl lactoyl-2-cyano acrylate | |
| Indermil | Henkel | n-Butyl-2-cyanoacrylate | |
| Liquiband | Advanced Medical Solutions | n-Butyl-2-cyanoacrylate | |
| Histoacryl | Tissueseal | n-Butyl-2-cyanoacrylate | |
| Glubran | GEM Italy | n-Butyl-2-cyanoacrylate/methacryloxysulpholane | |
| IFABond | IFA medical | N-Hexyl-2-cyanoacrylate | |
| TissuGlu | Cohera medical | Lysine di/tri isocyanate-PEG prepolymers | |
| HemCon | Bandage Pro | Chitosan | |
| Actamax | Actamax Surgical Material LLC | Dextran aldehyde, 8-arm PEG amine MW 10,000 functionalized with tris(2-aminoethyl)amine | |
| FocalSeal-L | Focal Inc. | Photopolymerizable PEG-co-poly(lactic acid)/poly(trimethylene carbonate) | |
| DuraSeal | Covidien | Tetra-NHS-derivatized PEG and trilysine | |
| CoSeal | Cohesion Technologies | Tetra-NHS-derivatized PEG and tetra-thiol-derivatized PEG | |
| SprayGel | Covidien | Tetra-NHS-derivatized PEG and tetra-amine-derivatized PEG | |
| TissuePatch | TissueMed | poly-((N-vinylpyrrolidone)50-co- (acrylic acid)25-co-(acrylic acid N-hydroxysuccinimide ester)25) | |
| OcuSeal | Hyperbranch Medical Technology | poly(glycerol succinic acid) and PEG–aldehyde | |
| Adherus | Hyperbranch | Activated PEG and branched poly(ethylene imine) |
Figure 3(A) Chemical structure of cPEG adhesive precursor. Photographs of precursor solution in phosphate-buffered saline before (B) and after (C) addition of aqueous sodium periodate solution; gel formation occurred within 20–30 s. (D) Analysis of islet graft and cPEG adhesive explants. Top row: photographic images of the site of cPEG adhesive-mediated 150-islet transplantation at the epididymal fat pad and liver surface, immediately before graft explant on day 112. Immobilized islet bolus is visible on the external liver surface. Black arrows, cPEG adhesive. Middle row: representative light micrographs of hematoxylin and eosin (H&E)-stained graft explants. Adhesive, AD; islet, IS; epididymal fat tissue, EF; liver tissue, L. Scale bars: 100 mm. Bottom row: representative fluorescent micrographs of the immunohistochemical triple stain of graft explants. Insulin, green; OX-41 (macrophage marker), blue; CD31 (endothelial cell marker), red. White arrows, non-specific cPEG labeling. All images, scale bar: 100 mm. 108 Copyright 2010, Elsevier.
Figure 4(A) Schematic fabrication of DCTA: in one pot, the gelatin–dopamine gluing macromers are first rapidly crosslinked by Fe3+ (first crosslink), at the same time, which are gradually crosslinked with genipin (second crosslink). (B) Gross view of the DCTA implants (with murine skins) extracted on day 4, 14, and 28, respectively, after subcutaneous implantation in mice. (C) Degradation of DCTA over time after implantation. H&E staining of the tissues surrounding DCTA after 4 (D), 14 (E), and 28 (F) days’ implantation; the DCTA is marked with an asterisk. scale bar:100 μm. 129 Copyright 2016, Elsevier.